Zelenskyy says Ukraine needs 'security guarantees' before Putin talks as he meets JD Vance in Munich
- 50
Ukraine's President Volodymyr Zelenskyy says he will only agree to meet his Russian counterpart Vladimir Putin after a common ...
Euronews
![Euronews](/medias/providers/euronews_en.jpg)
Welcome to the official Euronews YouTube channel!
Around the clock, our team of 500 journalists of more than 30 different nationalities gathers news with impartial perspective, beyond the headlines content and voices from across Europe and the world. Our YouTube channel has all this and more, bringing you selected and original content from the world's most trusted news source.
Our mission is to empower people to form their own opinion. We trust in people’s intelligence and ability to make up their own mind and seek to provide our audience with the greatest diversity of viewpoints through journalism that is unapologetically impartial. We don’t trade in bias and outrage, we focus on facts, ideas, and solutions. We believe all views matter.
Euronews was born out of a will to create a strong independent European news channel in 1993. As the only international news media with a European perspective, Euronews is where the world turns to hear what Europe has to say.
Check us out on ⬇️
Lastest news
- SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Integral Ad Science
- SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
- KSPI DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Joint Stock Company Kaspi.kz Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action First Filed by the Firm - KSPI
- SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira
- SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma
- SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals